+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome)



Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome)



Clinical and Experimental Pharmacology and Physiology 28(12): 1048-1052



1. Familial hyperkalaemic hypertension (FHH), also called pseudohypoaldosteronism type II (PHA2) or Gordon syndrome, is a rare Mendelian-form of low-renin hypertension. The first cases of FHH were reported approximately 30 years ago and they described the peculiar biochemical abnormalities (i.e. hyperkalaemia and hyperchloraemic acidosis despite a normal glomerular filtration rate). 2. Since then, more than 90 single cases and families have been reported in the literature. These various reports show marked differences in phenotype. 3. Our group has now collected 14 unrelated pedigrees originating from different parts of France and Europe. We confirm the large variations in the age of discovery and in the severity of the biochemical abnormalities from one individual to another and from one family to another one. 4. Blood pressure levels have no significant relationship with hyperkalaemia or hyperchloraemia, but there is a positive relationship with age, as in the normal population. 5. Analyses of clinical features and Mendelian segregation in our families demonstrate autosomal-dominant inheritance, as expected from the literature. 6. Efforts have been made in the past years to unravel the gene responsible for the disease. Until now, a primary responsibility of the gene encoding the thiazide-sensitive Na-Cl cotransporter (SLC12A3) has been excluded in PHA2 families. Three loci have been identified on chromosomes 1 (PHA2A), 17 (PHA2B) and 12 (PHA2C). 7. More recently, analysis of three additional pedigrees, including 10 affected subjects, with over 25 members allowed us to demonstrate further genetic heterogeneity and the existence of at least a fourth locus. 8. The genetic heterogeneity of this syndrome, and thus the variety of molecular defects, suggests the role of either several new components of the same pathway, multiple aldosterone- regulated effectors or direct or indirect partners of the Na-Cl cotransporter.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973884

Download citation: RISBibTeXText

PMID: 11903313


Related references

Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome). Clinical Science 126(10): 721-726, 2014

Genetic heterogeneity of familial hyperkalaemic hypertension. Journal of Hypertension 19(11): 1957-1964, 2001

Familial hyperkalemic hypertension (Gordon syndrome): evidence for phenotypic variability in a study of 7 families. Advances in Nephrology from the Necker Hospital 31: 55-68, 2001

Correlations between phenotypic and genetic heterogeneity in familial primary open-angle glaucoma and ocular hypertension. Investigative Ophthalmology & Visual Science 37(3): S456, 1996

Dehydrated hereditary stomatocytosis mimicking familial hyperkalaemic hypertension: clinical and genetic investigation. European Journal of Haematology 78(3): 253-259, 2007

Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease. Journal of Clinical Investigation 91(2): 677-683, 1993

Familial or genetic primary aldosteronism and Gordon syndrome. Endocrinology and Metabolism Clinics of North America 40(2): 343-68 Viii, 2011

Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity. Journal of the American College of Cardiology 34(1): 181-190, 1999

An inducible transgenic mouse model for familial hypertension with hyperkalaemia (Gordon's syndrome or pseudohypoaldosteronism type II). Clinical Science 124(12): 701-708, 2013

Linkage of Gordon's syndrome to the long arm of chromosome 17 in a region recently linked to familial essential hypertension. Journal of Human Hypertension 12(10): 675-678, 1998

Genetic and phenotypic heterogeneity in sporadic and familial forms of paroxysmal dyskinesia. Journal of Neurology 260(1): 93-99, 2013

Familial dilated cardiomyopathy with conduction disease exhibits both genetic and phenotypic heterogeneity. Circulation 92(8 Suppl. ): I83, 1995

Recurrent familial intrahepatic cholestasis in the Faeroe Islands. Phenotypic heterogeneity but genetic homogeneity. Hepatology 29(2): 506-508, 1999

Recurrent familial intrahepatic cholestasis in the Faroe Islands, phenotypic heterogeneity but genetic homogeneity. Hepatology 28(4 Part 2): 528A, 1998

6c.01: Cullin-3 Mutations Leading To Skipping Of Exon 9 Are Responsible For Severe Cases Of Familial Hyperkalaemic Hypertension. Journal of Hypertension 33 Suppl 1(): E79-E79, 2015